Forbes November 19, 2020
William A. Haseltine

The Food and Drug Administration has authorized the first rapid at-home test for Covid-19. It is a critical step forward in our efforts to contain the spread of disease, though the journey is far from complete.

The test, manufactured by Lucira Health, includes a nasal swab, sample vial, and a battery-operated testing device. Users swab each of their nostrils five times then stir the swab into the sample vial before pressing it into the testing unit. After 30 minutes, the testing device will shine green and indicate either a positive or negative test result. It is the first of its kind in the United States, and the only test that lets people swab themselves, analyze the sample, and receive...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Home, Patient / Consumer, Provider, Public Health / COVID
CDC: Thanks in part to fewer COVID-19 deaths, life expectancy rises slightly from 2021 to 2022
The art of the pandemic
Report recommends strengthening U.S. readiness for smallpox, related threats
STAT+: During the pandemic, were great vaccines bad business? A company-by-company review
Drinking water linked to 214 outbreaks in 5 years: CDC

Share This Article